We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

3 hedge funds and large institutions have $14.5M invested in Seelos Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $146K | Put options by funds: $128K

0% more funds holding

Funds holding: 3 → 3 (0)

13% less capital invested

Capital invested by funds: $16.6M → $14.5M (-$2.12M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$146K
Puts
$128K
Net Calls
+$18K
Net Calls Change
+$53K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
-$91K
2
Goldman Sachs
Goldman Sachs
New York
-$59K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$32K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$9.53M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.16M – – –
HVC
3
Healthcare Value Capital
New Jersey
$949K – – –
California Public Employees Retirement System
4
California Public Employees Retirement System
California
$377K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$373K – – –
BFA
6
BlackRock Fund Advisors
California
$188K – – –
Franklin Resources
7
Franklin Resources
California
$166K – – –
Northern Trust
8
Northern Trust
Illinois
$128K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$105K – – –
BIT
10
BlackRock Institutional Trust
California
$86K – – –
CC
11
Callan Capital
California
$81K – – –
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$76K – – –
HighTower Advisors
13
HighTower Advisors
Illinois
$72K – – –
Bank of America
14
Bank of America
North Carolina
$39K – – –
Group One Trading
15
Group One Trading
Illinois
$29K – – –
BA
16
BlackRock Advisors
Delaware
$18K – – –
SM
17
Sabby Management
Florida
$18K – – –
FANJ
18
Financial Architects (New Jersey)
New Jersey
$15K – – –
Morgan Stanley
19
Morgan Stanley
New York
$15K – – –
State Street
20
State Street
Massachusetts
$15K – – –
Wells Fargo
21
Wells Fargo
California
$15K – – –
BIM
22
BlackRock Investment Management
Delaware
$12K – – –
AIG
23
American International Group
New York
$9K – – –
Creative Planning
24
Creative Planning
Kansas
$9K – – –
UBS Group
25
UBS Group
Switzerland
$4K – – –
1
2

SEEL Hedge Fund Activity: Q3 2015 in Review

3 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q3 2015, worth a combined $14.5M — down 13% from $16.6M a quarter earlier.

Fund positioning in SEEL was balanced in Q3 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Brandes Investment Partners, cutting an estimated $91K.

  • 3 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q3 2015, unchanged from Q2 2015.
  • Funds reported $14.5M of Seelos Therapeutics, Inc. Common Stock stock for Q3 2015, down 13% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q3 2015 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q3 2015 was Brandes Investment Partners, an estimated $91K sold.

Based on aggregated 13F filings for Q3 2015.